Download Full eBooks in PDF
Medications Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Medications book. This book definitely worth reading, it is an incredibly well-written.
Author : Michael Mancano,Jason Gallagher
Publisher : Jones & Bartlett Learning
Page : 272 pages
File Size : 55,9 Mb
Release : 2010-11-12
Category : Medical
ISBN : 9780763781170
Health Sciences & Professions
Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Medication-Assisted Treatment for Opioid Use Disorder
Publisher : National Academies Press
Page : 175 pages
File Size : 47,9 Mb
Release : 2019-06-16
Category : Medical
ISBN : 9780309486484
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Author : Paul D. Thompson,Beth A. Taylor
Publisher : Springer Nature
Page : 191 pages
File Size : 55,8 Mb
Release : 2020-01-25
Category : Medical
ISBN : 9783030333041
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Author : Hans-Christoph Diener,Marcia Wilkinson
Publisher : Springer Science & Business Media
Page : 174 pages
File Size : 46,8 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9783642733277
M. WILKINSON Patients with frequent or daily headaches pose a very difficult problem for the physician who has to treat them, particularly as many patients think that there should be a medicine or medicines which give them instant relief. In the search for the compound which would meet this very natural desire, many drugs have been manufactured and the temptation for the physician is either to increase the dose of a drug which seems to be, at any rate, partially effective, or to add one or more drugs to those which the patient is already taking. Although there have been some references to the dangers of overdosage of drugs for migraine in the past, it was not until relatively recently that it was recognized that drugs given for the relief of headache, if taken injudiciously, may themselves cause headache. The first drugs to be implicated in this way were ergotamine and phenazone. In the case of ergotamine tartrate, the dangers of ergotism were well known as this was a disorder which had been known and written about for many years. In the treatment of headache, fully blown ergotism is rare and in recent years has usually been due to self-medication in doses much greater than those prescribed although there are a few recorded cases where toxic amounts have been given.
Author : Erma Z. Drobnis,Ajay K. Nangia
Publisher : Springer
Page : 325 pages
File Size : 44,5 Mb
Release : 2017-12-18
Category : Medical
ISBN : 9783319695358
The over-arching goal of this volume is to help infertility practitioners evaluate and manage their patients with poor semen quality. The authors review the existing literature on the effects of medications on male fertility, and provide detailed information about what is known, giving the number of individuals and population characteristics for studies of medication effects on male fertility. Medications are designed to treat illness and reduce symptoms, but all have undesirable adverse effects such as headache or stomach upset. Some adverse reactions can even be life-threatening, so it is no surprise that some drugs have negative effects on male reproduction. Medical practitioners rarely consider a man’s reproductive plans when prescribing medications. Men are routinely treated with drugs that can impair or abolish fertility. Although practitioners in the field of reproductive medicine generally realize that certain drugs impact negatively on reproductive health, there are limited resources providing evidence-based knowledge useful in counseling patients. Tables throughout this volume summarize the information for each drug, providing a handy reference for clinical use.
Author : Anonim
Publisher : Academic Press
Page : 288 pages
File Size : 52,5 Mb
Release : 2019-07-13
Category : Medical
ISBN : 9780128173176
Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series
Author : Lippincott Williams & Wilkins
Publisher : Lippincott Williams & Wilkins
Page : 2933 pages
File Size : 50,6 Mb
Release : 2021-03-04
Category : Medical
ISBN : 9781975160159
THE #1 Drug Guide for nurses & other clinicians...always dependable, always up to date! Look for these outstanding features: Completely updated nursing-focused drug monographs featuring 3,500 generic, brand-name, and combination drugs in an easy A-to-Z format NEW 32 brand-new FDA-approved drugs in this edition, including the COVID-19 drug remdesivir—tabbed and conveniently grouped in a handy “NEW DRUGS” section for easy retrieval NEW Thousands of clinical updates—new dosages and indications, Black Box warnings, genetic-related information, adverse reactions, nursing considerations, clinical alerts, and patient teaching information Special focus on U.S. and Canadian drug safety issues and concerns Photoguide insert with images of 439 commonly prescribed tablets and capsules
Author : Mary Patricia Tully,Bryony Dean Franklin
Publisher : CRC Press
Page : 340 pages
File Size : 45,6 Mb
Release : 2015-08-18
Category : Medical
ISBN : 9781482227017
An estimated 1 in 20 patients are admitted to the hospital due to problems with their medication and 1 in 100 hospitalized patients are harmed due to medication errors during their stay. The prescribing of medications is the most common health care intervention and medication safety is relevant to all health care professionals and patients, in all
Author : Anonim
Publisher : Unknown
Page : 571 pages
File Size : 40,6 Mb
Release : 2012
Category : Drugs
ISBN : 1283390612
Author : Sandra Kane-Gill,Joseph Dasta
Publisher : Springer Science & Business Media
Page : 160 pages
File Size : 44,8 Mb
Release : 2011-06-27
Category : Medical
ISBN : 9780857296061
Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
Author : Lynette L. Carl,Peter Roy Johnson
Publisher : Unknown
Page : 356 pages
File Size : 54,6 Mb
Release : 2006
Category : Medical
ISBN : IND:30000116079181
This pocket-sized reference is for clinicians who manage patients with dysphagia. Speech-language pathologists, occupational therapists, physicians, clinical dieticians, nurses, and pharmacists will find this book to be a helpful, handy resource. Drugs and Dysphagia is carefully organized, allowing quick access to precise information. The text comprises three parts: Part 1-overviews the nervous system and the swallow process. An overview of the effects of medications on swallowing is provided in Chapter 3. Part 2-addresses medications that affect the central nervous system. Medications associated with oral, pharyngeal, and esophageal dysphagia; causes of dysphagia; and drug-induced dysphagia are discussed. Part 3-deals with important medications that can cause dysfunction of the gastrointestinal system and those that are used to treat gastrointestinal dysfunction. Tables are included throughout for this quick and easy-to-use reference. These tables are organized into medication groups based on their use. Specific medications from each group are listed by both generic and brand name. The tables include the recommended doses of these medications; and the commonly encountered side effects associated with them, which may contribute to dysphagia.
Author : Thomas W. Hale, PhD
Publisher : Springer Publishing Company
Page : 736 pages
File Size : 46,8 Mb
Release : 2020-07-14
Category : Medical
ISBN : 9780826189264
Note to Readers: Publisher does not guarantee quality or access to any included digital components if book is purchased through a third-party seller. Written by a world-renowned expert in perinatal pharmacology, this essential reference contains current, complete, and evidence-based information on the transmission of maternal drugs into human milk. Because so many women ingest medications while breastfeeding, one of the most common questions encountered in pediatrics is: Which drugs are safe and which are hazardous for the infant? This 2021 edition has been extensively revised, and now includes 50 completely new and 356 updated medications, and state-of-the-art coverage of multiple diseases, vaccines, and syndromes. It addresses the use of radiopharmaceuticals, chemotherapeutic agents, and vaccines in breastfeeding mothers, and covers adult concerns, methods of reducing risk to infants, and infant monitoring. New to the 2021 Edition: 50 New Drugs Added 356 Drugs Updated with new data 817 Drug References Updated An updated 7x10 trim size and streamlined design for ease of use in patient education The latest information on the impact of prescription medications, over-the-counter drugs, herbs, and street drugs Key Features: Evidence-based, current information on over 1300 drugs, diseases, vaccines, and syndromes Dr. Hale's renowned "Lactation Risk Categories" incorporate recent updates Key points and savvy tips about breastfeeding and medications for quick reference Common abbreviations and drugs listed in alphabetical order Adult concerns, adult dose, pediatric concerns, infant monitoring, and alternatives Succinct information on evaluation of the infant Subscribe to www.springerpub.com/haleand experience all the benefits of using Hale's Medications and Mothers Milk online and on mobile devices! Go to www.springerpub.com/haleto learn more and subscribe today!
Author : Institute of Medicine,Committee on Quality of Health Care in America
Publisher : National Academies Press
Page : 312 pages
File Size : 43,5 Mb
Release : 2000-03-01
Category : Medical
ISBN : 9780309068376
Experts estimate that as many as 98,000 people die in any given year from medical errors that occur in hospitals. That's more than die from motor vehicle accidents, breast cancer, or AIDSâ€"three causes that receive far more public attention. Indeed, more people die annually from medication errors than from workplace injuries. Add the financial cost to the human tragedy, and medical error easily rises to the top ranks of urgent, widespread public problems. To Err Is Human breaks the silence that has surrounded medical errors and their consequenceâ€"but not by pointing fingers at caring health care professionals who make honest mistakes. After all, to err is human. Instead, this book sets forth a national agendaâ€"with state and local implicationsâ€"for reducing medical errors and improving patient safety through the design of a safer health system. This volume reveals the often startling statistics of medical error and the disparity between the incidence of error and public perception of it, given many patients' expectations that the medical profession always performs perfectly. A careful examination is made of how the surrounding forces of legislation, regulation, and market activity influence the quality of care provided by health care organizations and then looks at their handling of medical mistakes. Using a detailed case study, the book reviews the current understanding of why these mistakes happen. A key theme is that legitimate liability concerns discourage reporting of errorsâ€"which begs the question, "How can we learn from our mistakes?" Balancing regulatory versus market-based initiatives and public versus private efforts, the Institute of Medicine presents wide-ranging recommendations for improving patient safety, in the areas of leadership, improved data collection and analysis, and development of effective systems at the level of direct patient care. To Err Is Human asserts that the problem is not bad people in health careâ€"it is that good people are working in bad systems that need to be made safer. Comprehensive and straightforward, this book offers a clear prescription for raising the level of patient safety in American health care. It also explains how patients themselves can influence the quality of care that they receive once they check into the hospital. This book will be vitally important to federal, state, and local health policy makers and regulators, health professional licensing officials, hospital administrators, medical educators and students, health caregivers, health journalists, patient advocatesâ€"as well as patients themselves. First in a series of publications from the Quality of Health Care in America, a project initiated by the Institute of Medicine
Author : Robert H. Chew, Pharm.D.,Robert E. Hales, M.D., M.B.A.,Stuart C. Yudofsky, M.D.
Publisher : American Psychiatric Pub
Page : 488 pages
File Size : 44,9 Mb
Release : 2016-10-13
Category : Patient education
ISBN : 9781585625086
Designed and organized to answer the most common questions that patients have about their psychiatric medications, What Your Patients Need to Know About Psychiatric Medications, Third Edition, emphasizes clarity, accuracy, and accessibility of information. From Valium and Ativan to Prozac and Adderall, more than 70 medications from all of the major classes are discussed under eight key sections: General Information, Dosing Information, Common Side Effects, Adverse Reactions and Precautions, Risk During Pregnancy and Breast-Feeding, Potential Drug Interactions, Overdose, and Treatment Summary. Updated to reflect new medications that have come into the marketplace, as well as changes to the dosing, format, and methods of prescription of existing medications, What Your Patients Need to Know About Psychiatric Medications, Third Edition, is a comprehensive resource for practitioners—whether, clinical psychiatrists, clinical social workers, or psychiatric nurses—to educate their patients, and a source of practical information for patients themselves, long after they have left the doctor’s office.
Author : Francesco Pisani
Publisher : Elsevier Publishing Company
Page : 216 pages
File Size : 54,6 Mb
Release : 1991
Category : Medical
ISBN : UOM:39015024821962
The pharmacological fight against epilepsy began many centuries ago when Hippocrates discovered that the cause of epilepsy is natural, as opposed to supernatural and, as a consequence, must be treated with a natural remedy. Even though science has significantly progressed since that era, the challenge to find remedies for epilepsy is ever present. The aim of this particular volume is to offer an up-to-date review of the most recent advances in antiepileptic drug development, considered from various viewpoints: (i) general, by taking into account the size of refractory epilepsy and its related problems; (ii) experimental, by exploring the mechanisms of epileptogenesis and the possiblility of influencing it through drugs, and (iii) clinical, by describing the results obtained with compounds currently at an advanced stage of testing.